Introduced
by
To create a 24-member “opioid advisory commission” within the Legislative Council, a bipartisan entity that administers the legislative branch of state government. This would be comprised of specified political appointees and state officials, and would provide annual reviews of state government’s activities in this area. This would be in addition to a separate “Prescription Drug and Opioid Abuse Commission” in the Department of Licensing and Regulatory Affairs, which itself replaced an earlier Controlled Substances Advisory Commission, and an Advisory Committee on Pain and Symptom Management.
Referred to the Committee on Health Policy and Human Services
Reported without amendment
With the recommendation that the substitute (S-1) be adopted and that the bill then pass.
Passed in the Senate 33 to 0 (details)
Referred to the Committee on Judiciary
Reported without amendment
Without amendment and with the recommendation that the bill pass.
Passed in the House 91 to 13 (details)
To create a 24-member “opioid advisory commission” within the Legislative Council, a bipartisan entity that administers the legislative branch of state government. This would be comprised of specified political appointees and state officials, and would provide annual reviews of state government’s activities in this area. This would be in addition to a separate “Prescription Drug and Opioid Abuse Commission” in the Department of Licensing and Regulatory Affairs, which itself replaced an earlier Controlled Substances Advisory Commission, and an Advisory Committee on Pain and Symptom Management.